TD Cowen Maintains Buy on BeiGene, Raises Price Target to $254
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Werber maintains a Buy rating on BeiGene (NASDAQ:BGNE) and raises the price target from $236 to $254.

May 09, 2024 | 4:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BeiGene's Buy rating is maintained by TD Cowen, with an increased price target from $236 to $254.
The maintenance of a Buy rating combined with an increased price target typically signals a positive outlook on the company's future performance, suggesting an expectation of stock price appreciation. This is likely to influence investor sentiment positively in the short term, potentially leading to an increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100